Does CLINDAMYCIN Cause Bladder transitional cell carcinoma? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Bladder transitional cell carcinoma have been filed in association with CLINDAMYCIN (XACIATO). This represents 0.1% of all adverse event reports for CLINDAMYCIN.
23
Reports of Bladder transitional cell carcinoma with CLINDAMYCIN
0.1%
of all CLINDAMYCIN reports
0
Deaths
23
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From CLINDAMYCIN?
Of the 23 reports, 23 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLINDAMYCIN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does CLINDAMYCIN Cause?
Drug hypersensitivity (3,900)
Drug ineffective (1,894)
Rash (1,325)
Diarrhoea (1,206)
Off label use (901)
Nausea (803)
Pruritus (776)
Dyspnoea (607)
Condition aggravated (605)
Pyrexia (605)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which CLINDAMYCIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
CLINDAMYCIN vs CLINDAMYCIN\CLINDAMYCIN
CLINDAMYCIN vs CLINDAMYCIN\TRETINOIN
CLINDAMYCIN vs CLIOQUINOL
CLINDAMYCIN vs CLIOQUINOL\FLUMETHASONE
CLINDAMYCIN vs CLOBAZAM